BSE Live
Dec 26, 16:01Prev. Close
1968.35
Open Price
1963.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:53Prev. Close
1970.10
Open Price
1970.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1915.80 (24)
| Balance Sheet of Caplin Point Laboratories (in Rs. Cr.) | Jun 10 | Jun 09 | Jun 08 | Mar 07 | Jun 06 | |
| 12 mths | 12 mths | 15 mths | 9 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.11 | 15.11 | 13.01 | 13.01 | 13.01 | |
| Total Share Capital | 15.11 | 15.11 | 13.01 | 13.01 | 13.01 | |
| Reserves and Surplus | 6.59 | 5.02 | 2.80 | 0.98 | -0.46 | |
| Total Reserves and Surplus | 10.33 | 8.76 | 6.53 | 0.98 | -0.46 | |
| Total Shareholders Funds | 25.44 | 23.87 | 19.54 | 13.99 | 12.55 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.39 | 0.47 | 0.11 | 0.28 | 3.29 | |
| Deferred Tax Liabilities [Net] | 1.09 | 1.08 | 1.19 | 0.47 | 0.42 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1.48 | 1.56 | 1.30 | 0.75 | 3.71 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 9.98 | 8.09 | 10.85 | 6.54 | 6.45 | |
| Trade Payables | 10.97 | 11.70 | 13.57 | 8.19 | 10.12 | |
| Other Current Liabilities | 8.09 | 13.68 | 7.00 | 6.78 | 7.74 | |
| Short Term Provisions | 4.55 | 2.44 | 1.47 | 1.71 | 1.23 | |
| Total Current Liabilities | 33.59 | 35.90 | 32.90 | 23.22 | 25.54 | |
| Total Capital And Liabilities | 60.50 | 61.32 | 55.84 | 37.96 | 41.80 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 14.79 | 13.05 | 11.58 | 7.82 | 7.87 | |
| Intangible Assets | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 20.63 | 18.89 | 17.42 | 13.66 | 13.71 | |
| Non-Current Investments | 1.06 | 0.21 | 0.16 | 0.15 | 0.15 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.04 | 0.09 | |
| Total Non-Current Assets | 21.69 | 19.09 | 17.58 | 13.85 | 14.07 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 4.15 | 7.62 | 6.21 | 3.63 | 5.24 | |
| Trade Receivables | 9.03 | 8.86 | 11.88 | 12.45 | 11.13 | |
| Cash And Cash Equivalents | 14.64 | 16.91 | 10.33 | 3.62 | 5.78 | |
| Short Term Loans And Advances | 10.99 | 8.85 | 9.83 | 4.41 | 5.58 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 38.82 | 42.23 | 38.26 | 24.10 | 27.73 | |
| Total Assets | 60.50 | 61.32 | 55.84 | 37.96 | 41.80 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 4.88 | 4.48 | 3.96 | 0.69 | 0.69 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 25.01 | 29.46 | 25.56 | 6.53 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.17 | 0.09 | 0.17 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.74 | 0.62 | 0.66 | 0.80 | 0.20 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 51.07 | 48.79 | 41.35 | 18.51 | 3.24 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | 0.09 | 0.09 | |
| Non-Current Investments Unquoted Book Value | 0.99 | 0.00 | 0.00 | 0.01 | 0.01 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
28.08.2025
21.08.2025
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y